
DFTX
Healthcare · Biotechnology · $4.39B market cap
$32.08-0.92 (-2.8%)Nov 13, 4:15 PM EST
Next report
After the close
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -8.0% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Mar 4, 2027 · upcoming | After the close | -0.53 | — | — |
| Nov 9, 2026 | After the close | -0.55 | -0.46 | +16.4% |
| Aug 6, 2026 | After the close | -0.55 | -1.44 | -161.8% |
| May 7, 2026 | After the close | -0.49 | -0.71 | -44.9% |
| Feb 26, 2026 | Time not confirmed | -0.45 | -0.45 | 0.0% |
| Nov 6, 2025 | After the close | -0.50 | -0.78 | -56.0% |
| Jul 31, 2025 | After the close | -0.36 | -0.50 | -38.9% |
| May 8, 2025 | Before the open | -0.37 | -0.35 | +5.4% |
| Mar 6, 2025 | Time not confirmed | -0.31 | -0.41 | -32.3% |
| Nov 7, 2024 | After the close | -0.26 | -0.18 | +30.8% |
| Aug 13, 2024 | Before the open | -0.33 | -0.29 | +12.1% |
| May 8, 2024 | After the close | -0.56 | -1.14 | -103.6% |
| Feb 28, 2024 | Time not confirmed | -0.46 |
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company's lead product candidates DT120, which is in phase 3 for the treatment of generalized anxiety disorder, major depressive disorder, and other brain health disorders; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for…
| -2.44 |
| -427.1% |
| Nov 2, 2023 | After the close | -0.67 | -0.45 | +32.8% |
| Aug 3, 2023 | After the close | -0.53 | -0.76 | -43.4% |
| May 4, 2023 | After the close | -0.44 | -0.65 | -47.7% |
| Mar 9, 2023 | Time not confirmed | -0.13 | -0.13 | 0.0% |
| Nov 10, 2022 | Before the open | -0.63 | -0.56 | +11.1% |
| Aug 11, 2022 | After the close | -0.75 | -0.60 | +20.0% |
| May 16, 2022 | Before the open | -0.70 | -0.60 | +14.3% |
| Mar 28, 2022 | Time not confirmed | -0.60 | -0.04 | +93.3% |
| Nov 12, 2021 | Before the open | -0.55 | -0.90 | -63.6% |
| Aug 12, 2021 | After the close | -0.60 | -1.35 | -125.0% |
| Apr 6, 2021 | Time not confirmed | -0.30 | -0.04 | +86.7% |
| Nov 12, 2020 | After the close | -0.45 | -0.45 | 0.0% |
| Aug 14, 2020 | Time not confirmed | -0.30 | -0.02 | +93.3% |
| May 19, 2020 | Time not confirmed | — | -0.53 | — |
| Aug 31, 2019 | Time not confirmed | — | -1.62 | — |
| May 31, 2019 | Time not confirmed | — | -0.41 | — |
| Feb 28, 2019 | Time not confirmed | — | -0.47 | — |
| Nov 30, 2018 | Time not confirmed | — | -0.36 | — |
| Aug 31, 2018 | Time not confirmed | — | -0.62 | — |
| May 31, 2018 | Time not confirmed | — | -1.51 | — |
| Feb 28, 2018 | Time not confirmed | — | -0.78 | — |